Pyxis Oncology, Inc. (PYXS) Insider Ownership

Historic Insider Ownership Trends

As of April 17, 2026, Pyxis Oncology's top three insider holders are Inc Pfizer (TenPercentOwner, 5.95Mn shares), World Investments B.V. Bayer (Other, 2.74Mn shares), World Investments B.V. Bayer (Other, 2.74Mn shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Inc Pfizer - 5,952,263 0 23 Mar, 2023
World Investments B.V. Bayer - 2,742,338 0 15 Oct, 2021
World Investments B.V. Bayer - 2,742,338 0 15 Oct, 2021
World Investments B.V. Bayer - 2,742,338 0 15 Oct, 2021
Lara Sullivan President And Ceo 2,403,882 0 18 Sep, 2023
Pamela Ann Connealy Cfo Coo 0 2,314,886 27 Nov, 2024
Asset Management, Lp Cormorant - 0 1,118,854 15 Oct, 2021
Asset Management, Lp Cormorant - 0 1,118,854 15 Oct, 2021
Asset Management, Lp Cormorant - 0 1,118,854 15 Oct, 2021
Asset Management, Lp Cormorant - 0 1,118,854 15 Oct, 2021
Pamela Ann Connealy Cfo Coo 1,110,293 0 28 Mar, 2024
Jay Feingold Chief Medical Officer 730,345 0 28 Mar, 2023
Jitendra Wadhane Prin Fin Acct Officer 512,882 0 25 Mar, 2026
John L Flavin - 413,015 0 28 Mar, 2024
Darren S Cline - 251,405 0 28 Mar, 2024
Freda C Lewis-Hall - 241,405 0 28 Mar, 2024
Thomas Civik - 206,186 0 28 Mar, 2023
Rachel Humphrey - 96,805 0 28 Mar, 2024
Mark Chin - 66,831 0 04 Apr, 2022
Jakob Dupont - 38,741 0 28 Mar, 2024
Thomas Civik - 0 15,700 19 Nov, 2021
Santhosh Palani - 6,000 0 07 Jun, 2024

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
24 Mar, 2026 Santhosh Palani Stock Option (Right to Buy) A 45,867 $0.00 45,867 D A
24 Mar, 2026 Rachel Humphrey Stock Option (Right to Buy) A 45,867 $0.00 45,867 D A
24 Mar, 2026 Michael A Metzger Stock Option (Right to Buy) A 45,867 $0.00 45,867 D A
24 Mar, 2026 Jakob Dupont Stock Option (Right to Buy) A 45,867 $0.00 45,867 D A
24 Mar, 2026 Jitendra Wadhane Common Stock A 109,461 $0.00 512,882 D A
24 Mar, 2026 Darren S Cline Stock Option (Right to Buy) A 45,867 $0.00 45,867 D A
24 Mar, 2026 John L Flavin Stock Option (Right to Buy) A 45,867 $0.00 45,867 D A
24 Mar, 2026 Freda C Lewis-Hall Stock Option (Right to Buy) A 45,867 $0.00 45,867 D A
24 Mar, 2026 Jitendra Wadhane Stock Option (Right to Buy) A 262,635 $0.00 262,635 D A
03 Feb, 2026 Thomas Civik Stock Option (Right to Buy) A 690,131 $0.00 690,131 D A
31 Mar, 2025 Rachel Humphrey Stock Option (Right to Buy) A 36,979 $0.98 36,979 D A
31 Mar, 2025 John L Flavin Stock Option (Right to Buy) A 36,979 $0.98 36,979 D A
31 Mar, 2025 Freda C Lewis-Hall Stock Option (Right to Buy) A 36,979 $0.98 36,979 D A
31 Mar, 2025 Santhosh Palani Stock Option (Right to Buy) A 36,979 $0.98 36,979 D A
31 Mar, 2025 Michael A Metzger Stock Option (Right to Buy) A 36,979 $0.98 36,979 D A
31 Mar, 2025 Darren S Cline Stock Option (Right to Buy) A 36,979 $0.98 36,979 D A
31 Mar, 2025 Thomas Civik Stock Option (Right to Buy) A 36,979 $0.98 36,979 D A
31 Mar, 2025 Lara Sullivan Stock Option (Right to Buy) A 918,308 $0.98 918,308 D A
31 Mar, 2025 Pamela Ann Connealy Stock Option (Right to Buy) A 414,163 $0.98 414,163 D A
31 Mar, 2025 Jitendra Wadhane Stock Option (Right to Buy) A 263,782 $0.98 263,782 D A